Accessibility Menu
 
Biomind Labs logo

Biomind Labs

(OTC) BMNDF

Current Price$0.12
Market Cap$9.31M
Since IPO (2021)-52%
5 Year-99%
1 Year-83%
1 Month+991%

Biomind Labs Financials at a Glance

Market Cap

$9.31M

Revenue (TTM)

$0.00

Net Income (TTM)

$857.95K

EPS (TTM)

$-0.01

P/E Ratio

-10.91

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Price

$0.12

Volume

1,210

Open

$0.12

Previous Close

$0.12

Daily Range

$0.12 - $0.12

52-Week Range

$0.01 - $0.70

BMNDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biomind Labs

Industry

Pharmaceuticals

Employees

6

CEO

Alejandro Antalich

Headquarters

Canelones, UY

BMNDF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

55%

Return on Assets

-15%

Earnings Yield

-9.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.31M

Shares Outstanding

77.57M

Volume

1.21K

Avg. Volume

359.254

Financials (TTM)

Gross Profit

$2.27K

Operating Income

$861.42K

EBITDA

$859.15K

Operating Cash Flow

$68.73K

Capital Expenditure

$0.00

Free Cash Flow

$68.73K

Cash & ST Invst.

$147.00

Total Debt

$670.68K

Biomind Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$9.31M

N/A

Market Cap/Employee

$1.86M

N/A

Employees

5

N/A

Net Income

$573.02K

-432.6%

EBITDA

$560.37K

-3509.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$655.16K

+25.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$691.89K

-21.7%

Return on Assets

-14.88%

N/A

Return on Invested Capital

54.81%

N/A

Free Cash Flow

$49.81K

+51.5%

Operating Cash Flow

$49.80K

+51.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VCNXVaccinex, Inc.
$1.01+1.00%
ISCOInternational Stem Cell Corporation
$0.19+22.58%
ENZCEnzolytics Inc.
$0.00-12.50%
CBDYTarget Group Inc.
$0.00+38.46%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$198.48+0.00%
NOKNokia
$13.14-0.01%
CNSPCns Pharmaceuticals
$7.84+2.39%
GBTGGlobal Business Travel Group
$9.34+0.58%

Questions About BMNDF

What is the current price of Biomind Labs?

Biomind Labs is trading at $0.12 per share.

What is the 52-week range for Biomind Labs?

Over the past 52 weeks, Biomind Labs has traded between $0.01 and $0.70.

How much debt does Biomind Labs have?

As of the most recent reporting period, Biomind Labs reported total debt of $728,483.

How much cash does Biomind Labs have on hand?

Biomind Labs reported $36 in cash and cash equivalents in its most recent financial results.

What is Biomind Labs’s dividend yield?

Biomind Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.